Nicolas Winssinger
12Patents
5h-index
28Co-inventors
66Inventor score
Filing activity: Sep 4, 1997 → Oct 12, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6441186B1 | Epothilone analogs | Chemistry; Metallurgy | 44 | Expired |
| US6660758B1 | Epothilone analogs | Chemistry; Metallurgy | 21 | Expired |
| US9051302B2 | Synthesis of resorcylic acid lactones useful as therapeutic agents | Emerging Cross-Sectional Technologies | 10 | Active |
| US8067412B2 | Macrocyclic compounds useful as inhibitors of kinases and HSP90 | Chemistry; Metallurgy | 9 | Active |
| US8450305B2 | Macrocyclic compounds useful as inhibitors of kinases and HSP90 | Chemistry; Metallurgy | 8 | Active |
| US5965718A | Analogs of sarcodictyin and eleutherobin | Human Necessities | 5 | Expired |
| US8513440B2 | Compositions and methods comprising analogues of radicicol A | Chemistry; Metallurgy | 3 | Active |
| US7173137B2 | Epothilone analogs | Chemistry; Metallurgy | 3 | Expired |
| US10239856B2 | Synthesis of resorcylic acid lactones useful as therapeutic agents | Emerging Cross-Sectional Technologies | 1 | Active |
| US8329683B2 | Treatment of neurofibromatosis with radicicol and its derivatives | Human Necessities | 1 | Active |
| US8716191B2 | Method of preparing an adduct | Chemistry; Metallurgy | 0 | Active |
| US11827620B2 | Compounds and uses thereof for detection of target molecules in a sample | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.